Why the study?
Whether digital therapeutics can significantly improve sustainable lifestyle changes in hypertension remains controversial, with most studies lacking discussion on long-term gain challenges.
Does digital therapeutics improve sustainable lifestyle changes in patients with hypertension?
Does digital therapeutics improve sustainable lifestyle changes in patients with hypertension?
Digital therapeutics, particularly those utilizing AI and cognitive behavioral therapy, represent a promising strategy for promoting sustainable lifestyle modifications in hypertension management.
DTx for hypertension lack proof of sustainable lifestyle gains; leaves open need for long-term trials before clinical use.
Various digital therapeutic products have been validated and approved since 2017. They have demonstrated efficacy and safety as a new therapeutic modality in various disorders or conditions. Hypertension is a common but serious condition that can be prevented or controlled with lifestyle changes and medicines. Although a digital therapeutic in hypertension is validated and approved in Japan, whether digital therapeutics (DTx) can significantly improve sustainable lifestyle changes is still a controversial topic. Most studies did not discuss the long-term gain challenges. In this review, the authors discuss the definition of DTx, and analyze the motivation, engagement and adherence challenges of DTx in hypertension. Some ongoing artificial intelligence (AI)-enabled or cognitive behavioral therapy (CBT)-based digital interventions and behavioral strategies for implementing sustainable lifestyle changes are identified and analyzed. With AI-enabled interventions and behavioral strategies, DTx might be one of the effective approaches to make sustainable lifestyle changes.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: